IL-23R Inhibitor (Abbvie)

N/A

Report date: 2025/02/06 16:11:28
NME

Base Information

Drug NameIL-23R Inhibitor (Abbvie)
Drug Alias NameN/A
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionInterleukin 23 Receptor inhibitors
TargetsInterleukin 23 Receptor
Therapy Area/IndicationsPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNimble Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNimble Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsPsoriasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A